Vogue Business highlighted how FIT:MATCH's avatar technology is helping retailers reduce costly returns by improving fit accuracy for online shoppers. Read more on Vogue Business →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
